Man who raised £100k for charity since cancer diagnosis to take on 588-mile walk
Mr Dennington, who has raised more than £100,000 and awareness for Prostate Cancer UK since his diagnosis in February 2021, wants to fund research and a screening programme to help others.
He said: 'When I was diagnosed it felt surreal as I didn't have symptoms and thought I was pretty fit and healthy. I did feel guilt, though, as it was my body that was the reason my family were going to have to go through this journey.
'When I started fundraising, I thought I might raise up to £5,000 but it kind of took off. It has become a great source of positive focus, and I've met so many wonderful and generous people along the way. For this challenge I wanted to do something different and big that would grab attention, would encourage donations, be physically challenging and would be personally poignant for my fifth year.
'With the amazing support of my wife in particular, family and friends, I want to raise awareness of the cancer, its risks, drive testing and raise valuable funds to support those going through this terrible experience, to create a screening programme and for vital research.
'I want to help prevent other men and their families from going through the same journey as mine and to give hope to those who already are.'
He will set off from his place of birth in North Shields on Sunday, and the opening day will see him visit his first house, his former infant and junior school and will end at St James' Park, home to his boyhood football club, Newcastle United.
As he navigates his way south, Mr Dennington will visit key life landmarks, and pay tribute at the resting places of his late parents.
Mr Dennington's challenge finishes on September 7 when he reaches his current home in Hempstead where he has lived for the past 27 years. By which time he would have also scaled 27,375 feet, just shy of the summit of Mount Everest.
The serious message of his walk will also be shared via several awareness talks along the way.
Mr Dennington added: 'Caught early, prostate cancer is very treatable. However, I'm one of the circa 10,000 men a year caught too late to be cured and did not have obvious symptoms.
'For me, without a screening programme in the UK we rely heavily on well-informed and willing men to proactively get themselves tested. That is why raising awareness of risk is so important.'
Prostate Cancer UK chief executive Laura Kerby said: 'We're so grateful for the fantastic support from Paul as he tirelessly walks 588 miles to raise funds and celebrate his life.
'To say Paul is a force of nature would be an understatement. Despite his diagnosis, he has worked relentlessly to raise funds and awareness for Prostate Cancer UK, and his efforts are always whole-hearted. It's fair to say this is his most extreme to date, and I know this is a deeply personal journey for Paul, and is one he will tackle with the same grit and determination he has approached the last four and a half years.'
Mr Dennington has already raised more than £16,000 before the challenge starts, and has set himself a target of £30,000. You can view his page at www.justgiving.com/team/paul-dennington-march-through-life-team-page.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Scottish Sun
6 hours ago
- Scottish Sun
Thousands of men given ‘unnecessary' cancer treatment every year due to ‘wild west' guidelines
A leading cancer charity says "enough is enough" as it calls for Nice to update its advice 'HARMFUL' Thousands of men given 'unnecessary' cancer treatment every year due to 'wild west' guidelines Click to share on X/Twitter (Opens in new window) Click to share on Facebook (Opens in new window) UP to 5,000 men every could avoid unnecessary cancer treatment if "outdated" guidelines reflected latest evidence, a charity has urged. Overtreatment can lead to side effects such as erectile dysfunction or incontinence, it warned. Sign up for Scottish Sun newsletter Sign up 1 For men whose prostate cancer is unlikely to progress, experts suggest close monitoring is the "best" option - but advice on this hasn't been updated since 2021 Credit: Getty Prostate cancer is a leading cause of cancer deaths in males in the UK, with around 55,000 new cases diagnosed every year. However, in some cases, the cancer is slow-growing and unlikely to ever cause the patient harm. For men whose cancer is unlikely to progress, experts suggest close monitoring is the "best" option. However, out-of-date guidance from the National Institute of Health and Care Excellence (Nice) on how this is implemented has created a "wild west". Close monitoring involves blood tests and scans, known as active surveillance. Nice guidance on active surveillance is designed to advise specialists on how to implement monitoring and which men should be monitored. However, it hasn't been updated since 2021, according to Prostate Cancer UK. A Freedom of information (FOI) request analysis by the charity found around one in four (24 per cent) of hospitals rely on Nice guidance alone to implement active surveillance. It also found 35 hospitals have created their own guidelines, which Prostate Cancer UK warned can lead to inconsistency and confusion among medics. The charity is now repeating its call for Nice to update its guidance on active surveillance, claiming it could help up to 5,000 men a year avoid overtreatment. I thought I was drinking too much tea - but it was actually a deadly condition It also claims the outdated guidance is hindering a screening programme for prostate cancer. Amy Rylance, assistant director of health improvement at Prostate Cancer UK, said: "To reduce the harm caused by prostate cancer and build the foundations for a screening programme, we need to both save lives and prevent unnecessary treatment but official guidelines still haven't caught up with the clinical evidence. "Concerns about overtreatment are a major reason the UK does not routinely screen for prostate cancer, despite it being the most common cancer in England. "Acting on latest research that shows more men can safely opt for monitoring instead of treatment will reduce overtreatment and the harm it causes men. "We asked Nice to update their active surveillance guidance two years ago, but our request was rejected. Now we have evidence this is potentially affecting thousands of men. Enough is enough." Current testing for prostate cancer The NHS uses a prostate-specific antigen (PSA) blood test to check for prostate conditions, including prostate cancer or an enlarged prostate. Routine PSA testing is not currently offered on the NHS, but patients may be offered a PSA test if a GP suspects they have prostate cancer, while men over 50 can request a test from their GP even if they do not have symptoms. But there have been calls to roll the test out across the health service, although some argue widespread use could identify cases which may not have caused problems or needed treatment. Vincent Gnanapragasam, a professor of urology at the University of Cambridge, said: "Active surveillance is the best treatment option for men whose cancer is unlikely to progress or cause them problems in their lifetime. "But Nice's outdated guidelines have created a deeply concerning wild west on how surveillance is implemented by different healthcare teams. What is prostate cancer? Prostate cancer affects a small, walnut shaped gland that sits underneath the bladder and surrounds the urethra - the tube carrying pee outside the body. It usually grows bigger as you get older. The prostate's main job is to help make semen – the fluid that carries sperm. Most men with early prostate cancer don't have any signs or symptoms - that's why it's important to know about your risk. Possible symptoms include: Difficulty starting to urinate or emptying your bladder A weak flow when you urinate A feeling that your bladder hasn't emptied properly Dribbling urine after you finish urinating Needing to urinate more often than usual, especially at night A sudden need to urinate – you may sometimes leak urine before you get to the toilet If you do notice changes in the way you urinate, this is more likely to be a sign of an enlarged prostate, which is very common and non-cancerous. But it's still a good idea to get it checked out. In the UK, about one in eight men will be diagnosed with prostate cancer in their lifetime. Some factors may mean you're more likely to get it. This includes: Getting older – it mainly affects men aged 50 or over Having a family history of prostate cancer Being Black If you have any of these risk factors or if you have any symptoms, speak to your GP. They can talk to you about your risk, and about the tests that are used to diagnose prostate cancer. Source: Prostate Cancer UK "This inconsistency is resulting in a lack of confidence from patients in surveillance, who may instead opt to have treatment they may not have ever needed, risking harmful side effects. "Programmes for active surveillance that are standardised and individualised to a man's risk factors have been tested and proven to work." The UK's National Screening Committee is currently assessing whether a national screening programme for prostate cancer should be rolled out. A Nice spokesperson said: "We are committed to ensuring our guidelines continue to reflect the best available evidence and give patients the best possible outcomes. "They are developed by an independent committee, including NHS clinical experts, and are kept under review to ensure they remain current. "We are updating our prostate cancer guidelines, including a review of the recommendations around active surveillance, and will be assessing whether our suspected cancer guideline recommendations around age-related thresholds for PSA tests for prostate cancer for onwards referral from primary care require updating."
BBC News
6 hours ago
- BBC News
Men being over-treated for prostate cancer, says charity
The NHS is over-treating men for prostate cancer, a charity says, with around 5,000 a year undergoing treatment for cancers unlikely ever to cause one in four prostate cancers are so slow growing that men can opt for regular monitoring rather than treatment, such as surgery and radiotherapy, which can cause side-effects such as incontinence and erectile dysfunctionOf the 56,000 diagnosed in the UK each year, around 6,500 men opt for this, but an analysis by Prostate Cancer UK said another 5,000 could charity said outdated guidelines were to blame. The National Institute for Health and Care Excellence (NICE), which produces them, said it was reviewing its advice. NICE recommends that monitoring, using blood tests and scans, should be offered to the lowest risk cases, where nine in 10 will have no signs of cancer spreading within five research has suggested this could be extended to the next lowest risk group where eight in 10 men will have no signs of cancer spreading. Evidence gathered by Prostate Cancer UK suggests many hospitals have started offering monitoring to this wider group of patients, but a quarter have to the charity's analysis:in some hospitals in England, 24% of patients who could be monitored, instead undergo treatmentacross the UK, an average of 8% of men who could be monitored are treated instead, amounting to 5,000 a yearSome of this could be down to patient choice – men are generally given the option of treatment even if they are at the charity said if the NHS was more active in offering monitoring it could help strengthen the case for prostate cancer screening, which has gained traction since the diagnosis of Olympic cyclist Sir Chris argument against screening is that the prostate specific antigen (PSA) blood test, used to spot potential signs of the cancer, is unreliable and leads to unnecessary Rylance of Prostate Cancer UK, said: "To reduce the harm caused by prostate cancer and build the foundations for a screening programme, we need to both save lives and prevent unnecessary treatment."One patient who opted for monitoring was Michael Lewis, 63, from the West was diagnosed with prostate cancer in 2020 and, as it was judged low-risk, he opted for monitoring. Four years later tests suggested the cancer was worsening so he had his prostate removed. He said delaying treatment was so valuable."I was able to continue my everyday life with no side effects."NICE said the organisation was reviewing the prostate cancer guidelines and looking to update them."We are committed to ensuring our guidelines continue to reflect the best available evidence and give patients the best possible outcomes," said a spokesman.
The Independent
9 hours ago
- The Independent
Thousands of cancer patients could be undergoing unnecessary overtreatment
Up to 5,000 men in the UK could be undergoing unnecessary overtreatment for prostate cancer annually due to 'outdated' guidelines. Prostate Cancer UK warns that current National Institute of Health and Care Excellence (NICE) guidelines, last updated in 2021, do not account for advances in testing and diagnosis, leading to overtreatment. Overtreatment of slow-growing prostate cancers can result in severe side effects such as erectile dysfunction and incontinence, which could often be avoided with active monitoring. Experts describe a "wild west" or "postcode lottery" in care, with overtreatment rates varying significantly across England and many hospitals developing their own inconsistent guidelines.
